Neuropro Therapeutics, Inc.
Biotechnology company · Yachats, Oregon, United States
Neuropro Therapeutics, Inc. is a biotechnology company headquartered in Yachats, Oregon, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $5.1 million sold in a notice filed in 2023.
Neuropro Therapeutics at a glance
What does Neuropro Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $5.1 million sold (2023).
Frequently asked questions about Neuropro Therapeutics
Where is Neuropro Therapeutics headquartered?
Neuropro Therapeutics, Inc. is headquartered in Yachats, Oregon, United States.
What does Neuropro Therapeutics do?
Neuropro Therapeutics, Inc. is a biotechnology company.
When was Neuropro Therapeutics founded?
The earliest incorporation on record for Neuropro Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences